In terms of CEUS features, there were statistically significant differences in tumor enhancement level, rise time (RT), and time to peak (TTP) (p < 0.05) in the HER2‐negative/low group, and RT and TTP between the HER2‐positive/low group (p < 0.05). This evidence concerns the gene ERBB2 and neoplasm.